TECHNOLOGY SUMMARY

Neurovation Labs, Inc. is developing the first-ever objective diagnostic and companion precision medication for Post-traumatic Stress Disorder (PTSD) based on a groundbreaking brain biomarker discovery. PTSD is frequently diagnosed in both military as well as civilians after exposure to trauma. Neurovation Labs is transforming mental healthcare from art to science.

AREA/MATURITY/AWARDS

Primary Application Area: Biotech, Pharma, Health

Technology Development Status: Prototype

Technology Readiness Level: TRL 4

SHOWCASE SUMMARY

Organization Type: Early-stage Startup (Seed)

Website: http://www.neurovationlabs.com

MARKET KEYWORDS

Market Keywords: first-in-class, rapid diagnosis, precision treatment